-
Aspirin-Free Prasugrel Monotherapy Following Coronary Artery Stenting in Patients With Stable CAD: The ASET Pilot StudyN Kogame, PO Guimarães, PA Lemos et al. -
State of the art: duration of dual antiplatelet therapy after percutaneous coronary intervention and coronary stent implantation - past, present and future perspectives.Gargiulo G, Valgimigli M, Capodanno D et al.
-
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months versus aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicenter, open-label, randomized superiority trialP Vranckx, M Valgimigli, P Jüni et al.
-
Causes, Timing, and Impact of Dual Antiplatelet Therapy Interruption for Surgery (from the Patterns of Non-adherence to Anti-platelet Regimens In Stented Patients Registry)Schoos M, Chandrasekhar J, Mehran R et al.
-
Ticagrelor with or without Aspirin in High-Risk Patients after PCIR Mehran, U Baber, SK Sharma et al.
-
The optimal duration of dual antiplatelet therapy after coronary stent implantation: to go too far is as bad as to fall shortCosta F, Valgimigli M.
-
Patient Selection and Clinical Outcomes in the STOPDAPT-2 Trial: An All-Comer Single-Center Registry During the Enrollment Period of the STOPDAPT-2 Randomized Controlled TrialK Kanenawa, K Yamaji, H Tashiro et al.
-
Second-generation drug-eluting stent implantation followed by 6- versus 12-month dual antiplatelet therapy: the SECURITY randomized clinical trialColombo A, Chieffo A, Frasheri A et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
